{"product_id":"tilray-five-forces-analysis","title":"Tilray Brands Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Preview—Access the Full Strategic Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eTilray Brands faces intense rivalry and regulatory uncertainty, with supplier consolidation and shifting consumer preferences shaping margins and growth prospects.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Tilray Brands’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommoditization of Agricultural Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSoil, nutrients and water are undifferentiated commodities, keeping supplier power low for Tilray; input inflation for fertilizers rose ~12% in 2022 but normalized by 2024, easing cost pressure.\u003c\/p\u003e\n\u003cp\u003eTilray’s global supplier network—procurement across North America, Europe and Australia—means no single farm or vendor can dictate prices; 2024 bulk purchasing cut per-unit input costs by an estimated 6–8%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy and Utility Dependency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIndoor and hybrid greenhouse cultivation drives high electricity and water use, making utilities critical and typically rigid suppliers for Tilray; in 2024 Tilray reported cultivation energy costs representing roughly 12% of COGS for its Canadian operations.\u003c\/p\u003e\n\u003cp\u003eUtilities often act as regulated monopolies with limited competition, leaving Tilray little leverage to negotiate rates for large-scale facilities, especially in provinces like Ontario and British Columbia where grid tariffs rose ~8% in 2023.\u003c\/p\u003e\n\u003cp\u003eTo cut supplier power Tilray invested in energy-efficient LED lighting, HVAC upgrades and on-site solar and water-recycling systems, targeting a 20–25% reduction in consumption intensity by 2026 per internal sustainability targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Lab and Extraction Equipment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe production of high-margin derivatives like oils and beverages depends on sophisticated extraction and lab equipment from a small set of specialized manufacturers, giving suppliers moderate bargaining power; about 65% of global extractor capacity is concentrated among five vendors as of 2025. These machines are critical for meeting medical-grade standards and enabling product innovation, so Tilray mitigates risk by signing multi-year maintenance contracts and warranties. Tilray also diversifies procurement across North America, Europe, and Australia, reducing single-supplier exposure and cutting lead-time risk by an estimated 30%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVertical Integration Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTilray Brands has cut supplier power by vertically integrating cultivation, processing, and distribution, owning production sites and CC Pharma for pharma distribution, which reduced external procurement exposure and supplier markups.\u003c\/p\u003e\n\u003cp\u003eOwning these assets helped control quality and supply consistency for global markets; Tilray reported 2024 pro forma net revenue of about US$1.2 billion, supporting scale benefits and lower per-unit input volatility.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOwns cultivation\/processing sites — lowers input markup\u003c\/li\u003e\n\u003cli\u003eCC Pharma distribution — secures pharma channels\u003c\/li\u003e\n\u003cli\u003e2024 pro forma revenue ≈ US$1.2B — scale advantage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePackaging and Regulatory Compliance Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSuppliers of child-resistant packaging and regulatory labeling face tight government standards, limiting qualified vendors and letting niche suppliers charge premiums; FSRA and Health Canada rules raised compliance costs ~12% for Canadian cannabis firms in 2024.\u003c\/p\u003e\n\u003cp\u003eTilray leverages scale—global 2024 revenue $663M—to negotiate better rates, yet remains exposed to plastics and paper price swings (PVC up ~8% YoY, kraft paper +6% in 2024).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLimited qualified vendors → higher supplier power\u003c\/li\u003e\n\u003cli\u003eCompliance-ready materials command price premiums\u003c\/li\u003e\n\u003cli\u003eTilray scale ($663M revenue 2024) secures discounts\u003c\/li\u003e\n\u003cli\u003eInput-price sensitivity: PVC +8% YoY, kraft +6% 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMixed supplier power: extractors dominate but vertical integration and scale reduce risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is mixed: commodity inputs low power; utilities and specialized extractors moderate-to-high; packaging\/regulatory materials limited vendors raise premiums; vertical integration and 2024 scale (pro forma revenue US$1.2B; reported revenue US$663M) cut exposure.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (reported)\u003c\/td\u003e\n\u003ctd\u003eUS$663M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma revenue\u003c\/td\u003e\n\u003ctd\u003eUS$1.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExtractor supplier share\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy in COGS (Canada)\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Tilray Brands, this Porter's Five Forces overview uncovers competitive drivers, buyer and supplier power, entry barriers, and substitutes—highlighting disruptive threats and strategic levers that influence pricing, market share, and long-term profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Tilray Brands Porter’s Five Forces one-sheet—instantly shows supplier, buyer, entrant, substitute, and competitive pressures to speed strategic decisions for investors and management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProvincial Board Monopsony Power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn Canada, provincial liquor and cannabis boards act as near-monopsonies, controlling wholesale distribution and listing decisions, which forces Tilray Brands to accept standardized margins and strict delivery terms; for example, Ontario Cannabis Store accounted for ~40% of national cannabis retail volume in 2024. \u003c\/p\u003e\n\u003cp\u003eTilray counters by driving sell-through—its Canadian cannabis net revenue grew 12% YoY in FY2024—and investing in brand recognition and SKU performance to stay on board inventories and negotiate incremental listings. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow Consumer Switching Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIndividual consumers in recreational cannabis and craft beer face near-zero switching costs, so Tilray Brands must match competitors on price, potency, and lifestyle appeal to keep share; US cannabis price declines averaged ~12% in 2024, raising margin pressure. \u003c\/p\u003e\n\u003cp\u003eTilray uses data analytics and SKU rationalization—cutting ~15% underperforming SKUs in 2023—to iterate products faster and target segments where lifetime value is highest. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Sensitivity in Value Segments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eA large share of Canadian and US adult-use cannabis remains price-sensitive; surveys in 2024 showed ~38% of buyers prioritize lowest price per milligram THC, capping Tilray Brands’ pricing power and risking share loss to discount players like Trulieve and Cresco Labs. Tilray uses a tiered brand architecture—economy SKUs plus premium labels such as HEXO and Alberta Premium—to retain price-conscious users while extracting higher margins from connoisseurs. In 2025 Tilray reported gross margin compression in commoditized flower sales, so the dual-brand strategy aims to protect blended margins and volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetailer Consolidation and Influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpas the retail market consolidates large dispensary chains and multi-state operators gain leverage to demand shelf priority volume discounts exclusive launches pressuring producer margins in top u.s. msos controlled roughly of legal cannabis channels boosting negotiation power.\u003e\n\u003cptilray brands counters by offering a broad portfolio hexo good supply and manitoba harvest drives foot traffic cross-category sales helping secure preferred placement promotional slots with major retailers in fy2024 tilray reported consolidated net revenue of usd billion supporting trade investments.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eTop 10 MSOs ≈ 45% retail share (2024)\u003c\/li\u003e\u003cli\u003eTilray FY2024 revenue USD 1.15B\u003c\/li\u003e\u003cli\u003ePortfolio breadth wins shelf space\u003c\/li\u003e\u003cli\u003eRetailers push exclusives, volume discounts\u003c\/li\u003e\n\u003c\/ptilray\u003e\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Patient Retention and Expertise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMedical cannabis patients show higher loyalty than recreational users because specific strains and dosing matter, and Tilray reported ~45% of its Canadian medical customer base as repeat patients in FY2024, boosting recurring revenue.\u003c\/p\u003e\n\u003cp\u003eThese patients are well informed and demand quality and stock consistency; industry surveys in 2023 showed 62% would switch providers over supply gaps or inconsistent effects.\u003c\/p\u003e\n\u003cp\u003eTilray’s investments—over US$30m in medical research and patient education in 2024—aim to raise switching costs and reinforce trust.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e45% repeat rate in Canada (Tilray FY2024)\u003c\/li\u003e\n\u003cli\u003e62% would switch if supply\/quality lapses (2023 survey)\u003c\/li\u003e\n\u003cli\u003eUS$30m+ spent on research\/education in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustomers wield strong price power; Tilray defends margins with portfolio \u0026amp; cuts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomers hold moderate-to-high bargaining power: large provincial boards and MSOs (top 10 ≈45% US retail share in 2024) force margins and listing terms, while price‑sensitive recreational buyers (38% prioritize lowest $\/mg THC in 2024) cap pricing; medical patients raise switching costs (45% repeat rate in Canada, FY2024). Tilray offsets via broad portfolio, tiered brands, SKU cuts (~15% in 2023) and USD1.15B FY2024 revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (Year)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop 10 MSO retail share\u003c\/td\u003e\n\u003ctd\u003e≈45% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecreational price-sensitive buyers\u003c\/td\u003e\n\u003ctd\u003e38% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCanadian medical repeat rate\u003c\/td\u003e\n\u003ctd\u003e45% (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSKU cuts\u003c\/td\u003e\n\u003ctd\u003e~15% (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTilray revenue\u003c\/td\u003e\n\u003ctd\u003eUSD 1.15B (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eTilray Brands Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Porter's Five Forces analysis for Tilray Brands you'll receive immediately after purchase—no placeholders, no mockups.\u003c\/p\u003e\n\u003cp\u003eThe document displayed here is fully formatted and ready for download the moment you buy, containing the same supplier, buyer, rivalry, threat of entry, and substitution assessments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56746897867129,"sku":"tilray-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/tilray-five-forces-analysis.png?v=1772192973","url":"https:\/\/matrixbcg.com\/products\/tilray-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}